San Diego, CA, United States of America

Biovascular, Inc.


USPTO Granted Patents = 13

% Expired Patents = 30.8

Trademarks = 8

Forward Citations = 10,089

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Paul F Glidden (5 out of 8 patents)

silverMedal Kemal Schankereli (4 out of 44 patents)

bronzeMedal Joel Cooper (4 out of 4 patents)

4.  Alison J Pilgrim (3 out of 3 patents)

5.  Stephen R Hanson (3 out of 26 patents)

6.  Robert P Nelson (3 out of 3 patents)

7.  Sally L Winegar-Hentges (3 out of 3 patents)

8.  Kristine M Teich (3 out of 3 patents)

9.  Ralph T Francis (2 out of 3 patents)

10.  Anne E Claeson (2 out of 2 patents)

11.  B Nicholas Oray (1 out of 5 patents)

12.  Amy DeSmith (1 out of 2 patents)

13.  Qing Hong Zhao (1 out of 2 patents)

14.  Thomas Odland (1 out of 1 patent)

15.  Daniel G Holman (1 out of 1 patent)


13 patents:

Company Overview
Biovascular, Inc. is a biotechnology company based in San Diego, California, specializing in the development of innovative medical devices and therapeutic solutions. The organization focuses on advancing technologies that enhance vascular health and improve patient outcomes. With a commitment to research and development, Biovascular aims to address unmet medical needs through its expertise in biomaterials and regenerative medicine, contributing to the evolving landscape of healthcare solutions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#411 in San Diego, CA

#5,656 in California

#23,838 in US

#45,039 in the World

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 10,089

16 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biovascular, Inc.. Retrieved from https://idiyas.com/company/biovascular

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…